Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin, Interferon-alfa, Gemcitabine, and Hyperthermia in Advanced Pancreatic Cancer
NCT00082862Phase 2Unknown
- Sponsor
- UTHealth Houston
- Start
- Jul 2002
- Primary completion
- Nov 2012
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon alfa, cisplatin and gemcitabine in pancreatic cancer (PC), sponsored by UTHealth Houston. Primary endpoints: Tumor response, Toxicity and 2 more. Status: unknown.
02
Drugs
interferon alfacisplatingemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00082862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082862.